Expanding Master Files for human medicinal products in the EU/EEA
CEPI and EFPIA collaborated to author a regulatory position paper on master files in the EU. A new “Pharmaceutical Master File” overarching model is proposed that encompasses existing master files procedures as well as expanded approaches not in place today. The flexible and modular Pharmaceutical Master File aims at enabling faster access to novel medicines, including vaccines.
